| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| larotrectinib sulfate | Capsule, hard | 30.7 mg | Anticipated | Available | Unexpected increase in consumer demand | 6/07/2025 |
| benzathine benzylpenicillin tetrahydrate | Injection, suspension | 1200000 USP Unit | Current | Unavailable | Manufacturing | 4/07/2025 |
| levetiracetam | Tablet, film coated | 500 mg | Anticipated | Available | Manufacturing | 4/07/2025 |
| metronidazole | Tablet, uncoated | 400 mg | Current | Unavailable | Manufacturing | 4/07/2025 |
| galantamine hydrobromide | Capsule, modified release | 30.756 mg | Current | Limited Availability | Manufacturing | 4/07/2025 |
| quetiapine fumarate | Tablet, modified release | 460.52 mg | Current | Limited Availability | Manufacturing | 4/07/2025 |
| irbesartan~hydrochlorothiazide | Tablet, film coated | 300 mg~12.5 mg | Current | Unavailable | Manufacturing | 4/07/2025 |
| acarbose | Tablet | 100 mg | Anticipated | Available | Manufacturing | 4/07/2025 |
| irbesartan | Tablet, film coated | 150 mg | Current | Limited Availability | Manufacturing | 4/07/2025 |
| ivabradine hydrochloride | Tablet, film coated | 8.085 mg | Current | Unavailable | Manufacturing | 4/07/2025 |
| ivabradine hydrochloride | Tablet, film coated | 5.39 mg | Current | Unavailable | Manufacturing | 4/07/2025 |
| flucloxacillin sodium monohydrate | Injection, powder for | 544.1 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 4/07/2025 |
| sitagliptin hydrochloride monohydrate | Tablet, film coated | 56.69 mg | Current | Unavailable | Manufacturing | 4/07/2025 |
| daptomycin | Injection, powder for | 500 mg | Resolved | Available | Manufacturing | 4/07/2025 |
| dacarbazine | Injection, powder for | 200 mg | Current | Limited Availability | Manufacturing | 4/07/2025 |
| spironolactone | Tablet, film coated | 100 mg | Resolved | Available | Manufacturing | 4/07/2025 |
| pioglitazone hydrochloride | Tablet, uncoated | 16.53 mg | Current | Unavailable | Commercial Changes / Commercial viability | 4/07/2025 |
| lidocaine hydrochloride | Injection, solution | 10 mg/mL | Anticipated | Available | Manufacturing | 3/07/2025 |
| venlafaxine hydrochloride | Capsule, modified release | 169.71 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 3/07/2025 |
| risperidone | Tablet, film coated | 2 mg | Anticipated | Available | Manufacturing | 3/07/2025 |
| naloxone hydrochloride dihydrate~buprenorphine hydrochloride | Soluble Film | 2.44 mg~8.64 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 3/07/2025 |
| ezetimibe~rosuvastatin calcium | Tablet~Tablet, film coated | 10 mg~41.583 mg | Current | Limited Availability | Manufacturing | 3/07/2025 |
| bosentan monohydrate | Tablet, film coated | 129.082 mg | Anticipated | Available | Manufacturing | 3/07/2025 |
| midazolam | Injection, solution | 15 mg | Resolved | Available | Manufacturing | 3/07/2025 |
| ezetimibe~atorvastatin calcium trihydrate | Tablet, multilayer | 10 mg~86.8 mg | Resolved | Available | Manufacturing | 3/07/2025 |
| isotretinoin | Capsule, soft | 10 mg | Anticipated | Available | Manufacturing | 3/07/2025 |
| tranexamic acid | Tablet, film coated | 500 mg | Anticipated | Available | Manufacturing | 3/07/2025 |
| encorafenib | Capsule, hard | 50 mg | Current | Limited Availability | Manufacturing | 3/07/2025 |
| midodrine hydrochloride | Tablet | 5 mg | Current | Unavailable | Manufacturing | 3/07/2025 |
| erlotinib hydrochloride | Tablet, film coated | 27.32 mg | Anticipated | Available | Unexpected increase in consumer demand | 3/07/2025 |
| levothyroxine sodium | Tablet | .2 mg | Resolved | Available | Manufacturing | 3/07/2025 |
| rosuvastatin calcium | Tablet, film coated | 41.68 mg | Resolved | Available | Manufacturing | 3/07/2025 |
| sildenafil citrate | Tablet, film coated | 70.24 mg | Current | Unavailable | Unexpected increase in consumer demand | 3/07/2025 |
| fentanyl citrate | Injection, solution | 785 microgram | Current | Unavailable | Manufacturing | 3/07/2025 |
| cytarabine | Injection, solution | 100 mg/mL | Resolved | Available | Manufacturing | 3/07/2025 |
| lidocaine hydrochloride | Injection, solution | 10 mg/mL | Resolved | Available | Manufacturing | 3/07/2025 |
| lidocaine hydrochloride monohydrate | Injection, solution | 20 mg/mL | Anticipated | Available | Manufacturing | 3/07/2025 |
| lidocaine hydrochloride monohydrate | Injection, solution | 10 mg/mL | Current | Unavailable | Manufacturing | 3/07/2025 |
| lidocaine hydrochloride monohydrate | Injection, solution | 10 mg/mL | Current | Limited Availability | Manufacturing | 3/07/2025 |
| losartan potassium | Tablet, film coated | 50 mg | Resolved | Available | Unexpected increase in consumer demand | 3/07/2025 |
| zolpidem tartrate | Tablet, film coated | 10 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 3/07/2025 |
| Rubella virus~live varicella vaccine~Mumps virus~Measles virus | Injection, powder for | 1000 CCID50~1995 PFU~25119 CCID50~1000 CCID50 | Current | Unavailable | Manufacturing | 2/07/2025 |
| zolpidem tartrate | Tablet, film coated | 10 mg | Resolved | Available | Manufacturing | 2/07/2025 |
| acetylcholine chloride | Solution, powder for irrigation | 10 mg/mL | Current | Unavailable | Manufacturing | 2/07/2025 |
| metformin hydrochloride | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 2/07/2025 |
| metformin hydrochloride | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 2/07/2025 |
| sulfamethoxazole~trimethoprim | Injection, concentrated | 80 mg/mL~16 mg/mL | Current | Limited Availability | Manufacturing | 2/07/2025 |
| busulfan | Injection, concentrated | 60 mg | Resolved | Available | Manufacturing | 2/07/2025 |
| ceftazidime pentahydrate~avibactam sodium | Injection, powder for | 2329.7 mg~543.5 mg | Anticipated | Available | Unexpected increase in consumer demand | 2/07/2025 |
| teriflunomide | Tablet, film coated | 14 mg | Current | Unavailable | Manufacturing | 2/07/2025 |
| levothyroxine sodium | Tablet, uncoated | .05 mg | Current | Limited Availability | Manufacturing | 2/07/2025 |
| levothyroxine sodium | Tablet, uncoated | .075 mg | Current | Limited Availability | Manufacturing | 2/07/2025 |
| verapamil hydrochloride | Tablet, modified release | 240 mg | Current | Limited Availability | Manufacturing | 1/07/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 555 mg | Current | Unavailable | Manufacturing | 1/07/2025 |
| ropivacaine hydrochloride | Injection, solution | 150 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 1/07/2025 |
| nicorandil | Tablet | 20 mg | Current | Limited Availability | Manufacturing | 1/07/2025 |
| nicorandil | Tablet | 10 mg | Current | Unavailable | Manufacturing | 1/07/2025 |
| leuprorelin acetate~bicalutamide | Injection, modified release~Tablet, film coated | 22.5 mg~50 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 1/07/2025 |
| mesalazine | Tablet, enteric coated | 250 mg | Current | Unavailable | Manufacturing | 1/07/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Limited Availability | Manufacturing | 1/07/2025 |
| trimethoprim | Tablet, uncoated | 300 mg | Resolved | Available | Manufacturing | 1/07/2025 |
| pomalidomide | Capsule, hard | 2 mg | Current | Unavailable | Manufacturing | 1/07/2025 |
| carbidopa monohydrate~levodopa | Tablet, uncoated | 26.9 mg~100 mg | Resolved | Available | Manufacturing | 1/07/2025 |
| estradiol~norethisterone acetate | Drug delivery system, transdermal | .62 mg~2.7 mg | Resolved | Available | Manufacturing | 1/07/2025 |
| norethisterone acetate~estradiol | Drug delivery system, transdermal | 4.8 mg~.512 mg | Resolved | Available | Manufacturing | 1/07/2025 |
| minocycline hydrochloride dihydrate | Tablet, film coated | 54 mg | Resolved | Available | Manufacturing | 1/07/2025 |
| estradiol hemihydrate | Drug delivery system, transdermal | 2.32 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 1/07/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 20 mg | Anticipated | Available | Manufacturing | 1/07/2025 |
| nizatidine | Capsule | 150 mg | Current | Limited Availability | Manufacturing | 1/07/2025 |
| live varicella vaccine | Injection, powder for | 2700 PFU/mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 30/06/2025 |
| pentetic acid | Injection, powder for | 5 mg | Current | Unavailable | Manufacturing | 30/06/2025 |
| medronic acid | Injection, powder for | 10 mg | Current | Unavailable | Manufacturing | 30/06/2025 |
| sodium fluoride | Injection, concentrated | 1 mg/mL | Current | Unavailable | Manufacturing | 30/06/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 277.5 mg | Current | Unavailable | Manufacturing | 30/06/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 832.5 mg | Current | Unavailable | Manufacturing | 30/06/2025 |
| midazolam | Injection, solution | 5 mg | Current | Unavailable | Manufacturing | 30/06/2025 |
| tranexamic acid | Injection, solution | 1000 mg | Current | Unavailable | Commercial Changes / Commercial viability | 30/06/2025 |
| deoxycholic acid | Injection, solution | 10 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 30/06/2025 |
| voriconazole | Injection, powder for | 200 mg | Current | Unavailable | Commercial Changes / Commercial viability | 30/06/2025 |
| solifenacin succinate | Tablet | 5 mg | Current | Limited Availability | Manufacturing | 30/06/2025 |
| oxycodone hydrochloride | Injection, solution | 10 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 30/06/2025 |
| amikacin sulfate | Injection, solution | 333.76 mg/mL | Current | Unavailable | Manufacturing | 30/06/2025 |
| ezetimibe~atorvastatin calcium trihydrate | Tablet, film coated | 10 mg~20.681 mg | Resolved | Available | Manufacturing | 30/06/2025 |
| paclitaxel | Injection, powder for | 100 mg | Current | Limited Availability | Manufacturing | 30/06/2025 |
| finasteride | Tablet, film coated | 1 mg | Anticipated | Available | Manufacturing | 30/06/2025 |
| adapalene | Gel | 1 mg/g | Resolved | Available | Manufacturing | 30/06/2025 |
| Teriparatide | Injection, solution | 250 microgram/mL | Anticipated | Available | Manufacturing | 30/06/2025 |
2025年7月7日